Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROACTEMRA vs ROLAPITANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROACTEMRA vs ROLAPITANT: Safety Overview

Metric ROACTEMRA ROLAPITANT
Total FAERS Reports 164 873
Deaths Reported 14 252
Death Rate 8.5% 28.9%
Hospitalizations 65 155
Average Patient Age 51.2 yrs 61.4 yrs
% Female Patients N/A 57.5%
FDA Approval Date N/A Oct 25, 2017
Manufacturer N/A TerSera Therapeutics LLC
Route N/A ORAL
Marketing Status N/A Prescription